{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:38:14Z","timestamp":1791430694251,"version":"4.3.3"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s42770-023-00970-y","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T18:02:11Z","timestamp":1681495331000},"page":"679-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem"],"prefix":"10.1007","volume":"54","author":[{"given":"Sanjit","family":"Boora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulochana","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajoy Varma","family":"Bhupatiraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4835-6383","authenticated-orcid":false,"given":"Samander","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"970_CR1","unstructured":"WHO (2019) Hepatitis. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/hepatitis. Accessed 10 Oct 2022"},{"key":"970_CR2","unstructured":"WHO (2022) Hepatitis-b. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b Accessed 10 Oct 2022"},{"key":"970_CR3","doi-asserted-by":"crossref","unstructured":"Hoofnagle JH, Di Bisceglie AM (1991) Serologic diagnosis of acute and chronic viral hepatitis. In: Seminars in liver disease, vol 11, no. 02. Thieme Medical Publishers, Inc, pp 73\u201383","DOI":"10.1055\/s-2008-1040426"},{"issue":"6","key":"970_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264\u20131273","journal-title":"Gastroenterology"},{"issue":"S5","key":"970_CR5","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"Liang TJ (2009) Hepatitis B: the virus and disease. Hepatology 49(S5):S13\u2013S21","journal-title":"Hepatology"},{"issue":"8","key":"970_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/occmed\/kqr136","volume":"61","author":"EJ Aspinall","year":"2011","unstructured":"Aspinall EJ, Hawkins G, Fraser A et al (2011) Hepatitis B prevention, diagnosis, treatment and care: a review. Occup Med 61(8):531\u2013540","journal-title":"Occup Med"},{"issue":"5","key":"970_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4254\/wjh.v9.i5.227","volume":"9","author":"B Kayaaslan","year":"2017","unstructured":"Kayaaslan B, Guner R (2017) Adverse effects of oral antiviral therapy in chronic hepatitis B. World J Hepatol 9(5):227","journal-title":"World J Hepatol"},{"issue":"2","key":"970_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11(2):97\u2013107","journal-title":"J Viral Hepat"},{"issue":"9959","key":"970_CR9","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po C, Chan HL, Lok A (2014) Hepatitis B virus infection. The Lancet 384(9959):2053\u20132063","journal-title":"The Lancet"},{"issue":"18","key":"970_CR10","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.4254\/wjh.v7.i18.2127","volume":"7","author":"LC Meireles","year":"2015","unstructured":"Meireles LC, Marinho RT, Van Damme P (2015) Three decades of hepatitis B control with vaccination. World J Hepatol 7(18):2127","journal-title":"World J Hepatol"},{"key":"970_CR11","doi-asserted-by":"publisher","unstructured":"Wang J, Huang H, Liu Y, Chen R et al (2020) HBV genome and life cycle. In: Tang H (eds) Hepatitis B Virus Infection. Advances in experimental medicine and biology, vol 1179. Springer, Singapore, pp 17\u201337. https:\/\/doi.org\/10.1007\/978-981-13-9151-4_2","DOI":"10.1007\/978-981-13-9151-4_2"},{"issue":"6","key":"970_CR12","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/cells9061486","volume":"9","author":"C Herrscher","year":"2020","unstructured":"Herrscher C, Roingeard P, Blanchard E (2020) Hepatitis B virus entry into cells. Cells 9(6):1486","journal-title":"Cells"},{"issue":"2","key":"970_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/jgh.13175","volume":"31","author":"CN Hayes","year":"2016","unstructured":"Hayes CN, Zhang Y, Makokha GN et al (2016) Early events in hepatitis B virus infection: from the cell surface to the nucleus. J Gastroenterol Hepatol 31(2):302\u2013309","journal-title":"J Gastroenterol Hepatol"},{"issue":"17","key":"970_CR14","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1128\/JVI.00873-12","volume":"86","author":"HC Huang","year":"2012","unstructured":"Huang HC, Chen CC, Chang WC et al (2012) Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis. Virol J 86(17):9443\u20139453","journal-title":"Virol J"},{"key":"970_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-cellbio-100814-125241","volume":"31","author":"W Li","year":"2015","unstructured":"Li W (2015) The hepatitis B virus receptor. Annu Rev Cell Dev Biol 31:125\u2013147","journal-title":"Annu Rev Cell Dev Biol"},{"key":"970_CR16","doi-asserted-by":"crossref","unstructured":"Yan H, Zhong G, Xu G et al (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049","DOI":"10.7554\/eLife.00049"},{"key":"970_CR17","unstructured":"Salhab A, Amer J, Safadi R (2018) Sodium taurocholate co-transporting polypeptide (NTCP) as novel checkpoint in NK cells activity in liver fibrosis. In: Hepatology, vol 68, pp 647A-648A. Wiley, Hoboken, pp 07030\u20135774"},{"key":"970_CR18","doi-asserted-by":"publisher","unstructured":"Bowden S, Jackson K, Littlejohn M, Locarnini S (2004) Quantification of HBV covalently closed circular DNA from liver tissue by Real-Time PCR. In: Hamatake RK, Lau JYN (eds) Hepatitis B and D Protocols. Methods in Molecular Medicine, vol 95. Humana Press, pp 41\u201350. https:\/\/doi.org\/10.1385\/1-59259-669-X:41","DOI":"10.1385\/1-59259-669-X:41"},{"issue":"4","key":"970_CR19","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1073\/pnas.98.4.1841","volume":"98","author":"H Tang","year":"2001","unstructured":"Tang H, McLachlan A (2001) Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. PNAS 98(4):1841\u20131846","journal-title":"PNAS"},{"issue":"2","key":"970_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jhep.2009.10.031","volume":"52","author":"S Urban","year":"2010","unstructured":"Urban S, Schulze A, Dandri M, Petersen J (2010) The replication cycle of hepatitis B virus. J Hepatol 52(2):282\u2013284","journal-title":"J Hepatol"},{"issue":"5","key":"970_CR21","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","volume":"55","author":"J Lucifora","year":"2011","unstructured":"Lucifora J, Arzberger S, Durantel D et al (2011) Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 55(5):996\u20131003","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"970_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","volume":"134","author":"M Nassal","year":"2008","unstructured":"Nassal M (2008) Hepatitis B viruses: reverse transcription a different way. Virus Res 134(1\u20132):235\u2013249","journal-title":"Virus Res"},{"issue":"1","key":"970_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2013.56","volume":"2","author":"SA Jones","year":"2013","unstructured":"Jones SA, Hu J (2013) Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention. Emerg Microbes Infect 2(1):1\u201311","journal-title":"Emerg Microbes Infect"},{"key":"970_CR24","doi-asserted-by":"crossref","unstructured":"Dandri M, Petersen J (2016) Mechanism of hepatitis B virus persistence in hepatocytes and its carcinogenic potential. Clin Infect Dis 62(suppl_4):S281\u2013S288","DOI":"10.1093\/cid\/ciw023"},{"issue":"9","key":"970_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.15698\/mic2016.09.527","volume":"3","author":"T Inoue","year":"2016","unstructured":"Inoue T, Tanaka Y (2016) Hepatitis B virus and its sexually transmitted infection-an update. Microbial Cell 3(9):420","journal-title":"Microbial Cell"},{"issue":"2","key":"970_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/jmv.20182","volume":"74","author":"A Mariano","year":"2004","unstructured":"Mariano A, Mele A, Tosti ME et al (2004) Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy. J Med Virol 74(2):216\u2013220","journal-title":"J Med Virol"},{"issue":"4","key":"970_CR27","first-page":"318","volume":"26","author":"PW Hui","year":"2020","unstructured":"Hui PW, Ng C, Cheung KW, Lai CL (2020) Acceptance of antiviral treatment and enhanced service model for pregnant patients carrying hepatitis B. Hong Kong Med J 26(4):318","journal-title":"Hong Kong Med J"},{"issue":"1","key":"970_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/infdis\/142.1.67","volume":"142","author":"RM Scott","year":"1980","unstructured":"Scott RM, Snitbhan R, Bancroft WH et al (1980) Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis 142(1):67\u201371","journal-title":"J Infect Dis"},{"issue":"6485","key":"970_CR29","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1136\/bmj.290.6485.1853","volume":"290","author":"P Karayiannis","year":"1985","unstructured":"Karayiannis P, Novick DM, Lok AS et al (1985) Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br Med J (Clin Res Ed) 290(6485):1853\u20131855","journal-title":"Br Med J (Clin Res Ed)"},{"key":"970_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9482607","author":"HJ Hebo","year":"2019","unstructured":"Hebo HJ, Gemeda DH, Abdusemed KA (2019) Hepatitis B and C viral infection: prevalence, knowledge, attitude, practice, and occupational exposure among healthcare workers of Jimma University Medical Center, southwest Ethiopia. Sci World J. https:\/\/doi.org\/10.1155\/2019\/9482607","journal-title":"Sci World J"},{"key":"970_CR31","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.2147\/JMDH.S334438","volume":"14","author":"R Roien","year":"2021","unstructured":"Roien R, Mousavi SH, Ozaki A et al (2021) Assessment of knowledge, attitude, and practice of health-care workers towards hepatitis B virus prevention in Kabul, Afghanistan. JMDH 14:3177","journal-title":"JMDH"},{"issue":"5","key":"970_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4254\/wjh.v8.i5.273","volume":"8","author":"N Coppola","year":"2016","unstructured":"Coppola N, De Pascalis S, Onorato L et al (2016) Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol 8(5):273","journal-title":"World J Hepatol"},{"issue":"1","key":"970_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.7150\/ijms.2.50","volume":"2","author":"J Hou","year":"2005","unstructured":"Hou J, Liu Z, Gu F (2005) Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2(1):50","journal-title":"Int J Med Sci"},{"issue":"3","key":"970_CR34","first-page":"333","volume":"7","author":"AN Aljarbou","year":"2013","unstructured":"Aljarbou AN (2013) The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia. Int J Health Sci 7(3):333","journal-title":"Int J Health Sci"},{"issue":"6","key":"970_CR35","doi-asserted-by":"publisher","first-page":"716","DOI":"10.4269\/ajtmh.2003.68.716","volume":"68","author":"JC Russi","year":"2003","unstructured":"Russi JC, Serra M, Vi\u00f1oles J et al (2003) Sexual transmission of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 infections among male transvestite comercial sex workers in Montevideo, Uruguay. Am J Trop Med 68(6):716\u2013720","journal-title":"Am J Trop Med"},{"issue":"2","key":"970_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1365-2893.2009.01158.x","volume":"17","author":"R Van Houdt","year":"2010","unstructured":"Van Houdt R, Bruisten SM, Geskus RB et al (2010) Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. J Viral Hepat 17(2):108\u2013114","journal-title":"J Viral Hepat"},{"key":"970_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejogrb.2020.11.052","volume":"256","author":"VN Chilaka","year":"2021","unstructured":"Chilaka VN, Konje JC (2021) Viral hepatitis in pregnancy. Eur J Obstet Gynecol 256:287\u2013296","journal-title":"Eur J Obstet Gynecol"},{"issue":"2","key":"970_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/oxfordjournals.aje.a112370","volume":"105","author":"RP Beasley","year":"1977","unstructured":"Beasley RP, Trepo C, Stevens CE, Szmuness W (1977) The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 105(2):94\u201398","journal-title":"Am J Epidemiol"},{"issue":"4","key":"970_CR39","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","volume":"20","author":"KC Hyams","year":"1995","unstructured":"Hyams KC (1995) Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20(4):992\u20131000","journal-title":"Clin Infect Dis"},{"issue":"10003","key":"970_CR40","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT et al (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet 386(10003):1546\u20131555","journal-title":"The Lancet"},{"key":"970_CR41","doi-asserted-by":"crossref","unstructured":"Custer B, Sullivan SD, Hazlet TK et al (2004) Global epidemiology of hepatitis B. virus J Clin Gastroenterol 38(10):S158\u2013S168","DOI":"10.1097\/00004836-200411003-00008"},{"issue":"1","key":"970_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard CW, Simard EP, Finelli L et al (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28(1):112\u2013125","journal-title":"Epidemiol Rev"},{"issue":"1","key":"970_CR43","first-page":"15","volume":"2","author":"YP Yan","year":"2014","unstructured":"Yan YP, Su HX, Ji Z et al (2014) Epidemiology of hepatitis B virus infection in China: current status and challenges. J Clin Transl Hepatol 2(1):15","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"970_CR44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"D Razavi-Shearer","year":"2018","unstructured":"Razavi-Shearer D, Gamkrelidze I, Nguyen MH et al (2018) Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol 3(6):383\u2013403","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"970_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.12.2.351","volume":"12","author":"FJ Mahoney","year":"1999","unstructured":"Mahoney FJ (1999) Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 12(2):351\u2013366","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"970_CR46","first-page":"312","volume":"4","author":"P Puri","year":"2014","unstructured":"Puri P (2014) Tackling the hepatitis B disease burden in India. JCEH 4(4):312\u2013319","journal-title":"JCEH"},{"issue":"12","key":"970_CR47","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott JJ, Stevens GA, Groeger J, Wiersma (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30(12):2212\u20132219","journal-title":"Vaccine"},{"issue":"1","key":"970_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-12-378","volume":"12","author":"A Khosravani","year":"2012","unstructured":"Khosravani A, Sarkari B, Negahban H et al (2012) Hepatitis B Infection among high risk population: a seroepidemiological survey in Southwest of Iran. BMC infec dis 12(1):1\u20134","journal-title":"BMC infec dis"},{"issue":"4","key":"970_CR49","first-page":"263","volume":"11","author":"A Ozer","year":"2011","unstructured":"Ozer A, Yakupogullari Y, Beytur A et al (2011) Risk factors of hepatitis B virus infection in Turkey: a population-based, case-control study: risk factors for HBV infection. Hepat Mon 11(4):263","journal-title":"Hepat Mon"},{"key":"970_CR50","doi-asserted-by":"crossref","unstructured":"Chu CM, Liaw YF (2016) Natural history of hepatitis B virus infection. In: Hepatitis B virus in human diseases. Humana Press, Cham, pp 217\u2013247","DOI":"10.1007\/978-3-319-22330-8_11"},{"issue":"2","key":"970_CR51","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/hep.21513","volume":"45","author":"AS Lok","year":"2007","unstructured":"Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology-Baltimore then Orlando- 45(2):507","journal-title":"Hepatology-Baltimore then Orlando-"},{"issue":"1","key":"970_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2012.12.004","volume":"87","author":"M Mandal\u00e0","year":"2013","unstructured":"Mandal\u00e0 M, Fagiuoli S, Francisci D et al (2013) Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis. Crit Rev Oncol 87(1):12\u201327","journal-title":"Crit Rev Oncol"},{"key":"970_CR53","doi-asserted-by":"publisher","unstructured":"Nishikawa H, Osaki Y (2015) Liver cirrhosis: evaluation, nutritional status, and prognosis. Mediators Inflamm 2015. https:\/\/doi.org\/10.1155\/2015\/872152","DOI":"10.1155\/2015\/872152"},{"issue":"5","key":"970_CR54","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","volume":"56","author":"EL Ellis","year":"2012","unstructured":"Ellis EL, Mann DA (2012) Clinical evidence for the regression of liver fibrosis. J Hepatol 56(5):1171\u20131180","journal-title":"J Hepatol"},{"key":"970_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0168-8278(03)00139-9","volume":"39","author":"G Fattovich","year":"2003","unstructured":"Fattovich G (2003) Natural history of hepatitis B. J Hepatol 39:50\u201358","journal-title":"J Hepatol"},{"key":"970_CR56","first-page":"1","volume":"1","author":"J Wu","year":"2022","unstructured":"Wu J, Ge L, Lu L (2022) Letter to the editor on \u201cPerfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis\u201d. Abdom Radiol 1:1\u20132","journal-title":"Abdom Radiol"},{"key":"970_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2147\/JHC.S316223","volume":"25","author":"YX Pan","year":"2021","unstructured":"Pan YX, Sun XQ, Hu ZL et al (2021) Prognostic values of alpha-fetoprotein and des-gamma-carboxyprothrombin in hepatocellular carcinoma in China: An analysis of 4792 patients. J Hepatocell 25:657\u2013670","journal-title":"J Hepatocell"},{"issue":"5","key":"970_CR58","first-page":"775","volume":"60","author":"MJ King","year":"2022","unstructured":"King MJ, Laothamatas I, Reddy A, Wax R, Lewis S (2022) Cross-sectional imaging findings of atypical liver malignancies and diagnostic pitfalls: emphasis on computed tomography, and magnetic resonance imaging. Radiologic Clinics 60(5):775\u2013794","journal-title":"Radiologic Clinics"},{"key":"970_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.639963","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu R, Li Y, Wu A et al (2021) Identification of plasma hsa_circ_0005397 and combined with serum AFP, AFP-L3 as potential biomarkers for hepatocellular carcinoma. Front pharmacol 12:639963","journal-title":"Front pharmacol"},{"issue":"11","key":"970_CR60","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.3390\/cancers12113218","volume":"12","author":"GP Caviglia","year":"2020","unstructured":"Caviglia GP, Ciruolo M, Abate ML et al (2020) Alpha-fetoprotein, protein induced by vitamin K absence or antagonist II and glypican-3 for the detection and prediction of hepatocellular carcinoma in patients with cirrhosis of viral etiology. Cancers 12(11):3218","journal-title":"Cancers"},{"key":"970_CR61","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/IJGM.S253622","volume":"18","author":"OM Ali","year":"2020","unstructured":"Ali OM, El Amin HA, Sharkawy YL et al (2020) Golgi protein 73 versus alpha-fetoprotein as a new biomarker in early diagnosis of hepatocellular carcinoma. Int J Gen Med 18:193\u2013200","journal-title":"Int J Gen Med"},{"issue":"4","key":"970_CR62","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.aohep.2020.01.001","volume":"19","author":"R Bruha","year":"2020","unstructured":"Bruha R, Vitek L, Smid V (2020) Osteopontin\u2013A potential biomarker of advanced liver disease. Ann Hepatol 19(4):344\u2013352","journal-title":"Ann Hepatol"},{"issue":"5","key":"970_CR63","first-page":"2801","volume":"23","author":"T Suda","year":"2022","unstructured":"Suda T, Yamashita T, Sunagozaka H et al (2022) (2022) Dickkopf-1 promotes angiogenesis and is a biomarker for hepatic stem cell-like hepatocellular carcinoma. Int J Biol Sci 23(5):2801","journal-title":"Int J Biol Sci"},{"issue":"9","key":"970_CR64","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.7150\/ijbs.44024","volume":"16","author":"X Wu","year":"2020","unstructured":"Wu X, Li J, Gassa A et al (2020) Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma. Int J Biol Sci 16(9):1551","journal-title":"Int J Biol Sci"},{"issue":"2","key":"970_CR65","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/15321819.2023.2168556","volume":"44","author":"OG Osasona","year":"2023","unstructured":"Osasona OG, Oguntoye T, Eromon P et al (2023) Atypical serologic profiles of hepatitis B virus infection across clinical cohorts of patients in Southwestern Nigeria. J Immunoass Immunochem 44(2):176\u2013191","journal-title":"J Immunoass Immunochem"},{"issue":"6","key":"970_CR66","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2174\/1389201022666210719162802","volume":"23","author":"M Zangiabadian","year":"2022","unstructured":"Zangiabadian M, Zamani A, Nasiri MJ, Behzadi E, Fooladi AA (2022) Diagnostic accuracy and validity of serological and molecular tests for hepatitis B and C. Curr Pharm Biotechnol 23(6):803\u2013817","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"970_CR67","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1128\/JCM.01519-07","volume":"46","author":"SD Pas","year":"2008","unstructured":"Pas SD, Tran N, de Man RA, Burghoorn-Maas C, Vernet G, Niesters HG (2008) Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus. J Clin Microbiol 46(4):1268\u20131273","journal-title":"J Clin Microbiol"},{"issue":"2","key":"970_CR68","first-page":"143","volume":"9","author":"J Liang","year":"2021","unstructured":"Liang J, Liang X, Ma H, Nie L, Tian Y, Chen G, Wang Y (2021) Detection of hepatitis B virus M204V mutation quantitatively via real-time PCR. J Clin Transl Hepatol 9(2):143","journal-title":"J Clin Transl Hepatol"},{"key":"970_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.731415","volume":"9","author":"X Chen","year":"2021","unstructured":"Chen X, Wang S, Tan Y, Huang J, Yang X, Li S (2021) Nanoparticle-based lateral flow biosensors integrated with loop-mediated isothermal amplification for the rapid and visual diagnosis of hepatitis B virus in clinical application. Front Bioeng Biotechnol 9:731415","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"970_CR70","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/hep.1840210308","volume":"21","author":"S Takano","year":"1995","unstructured":"Takano S, Yokosuka O, Imazeki F et al (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatol 21(3):650\u2013655","journal-title":"Hepatol"},{"key":"970_CR71","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1046\/j.1440-1746.2000.02097.x","volume":"15","author":"CM Chu","year":"2000","unstructured":"Chu CM (2000) Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 15:E25\u2013E30","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"970_CR72","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/apt.13634","volume":"43","author":"F Liu","year":"2016","unstructured":"Liu F, Wang XW, Chen L et al (2016) Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance. Aliment Pharmacol Ther 43(12):1253\u20131261","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"970_CR73","first-page":"238","volume":"48","author":"A Ozakyol","year":"2017","unstructured":"Ozakyol A (2017) Global epidemiology of hepatocellular carcinoma (HCC epidemiology). JGO 48(3):238\u2013240","journal-title":"JGO"},{"issue":"12","key":"970_CR74","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1111\/jgh.15079","volume":"35","author":"TCF Yip","year":"2020","unstructured":"Yip TCF, Wong GLH, Chan HLY et al (2020) Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus. J Gastroenterol Hepatol 35(12):2210\u20132219","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"970_CR75","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/vaccines9080838","volume":"9","author":"R Bashir Hamidu","year":"2021","unstructured":"Bashir Hamidu R, Chalikonda DM, Hann HW (2021) Gender disparity in host responses to hepatitis B-related hepatocellular carcinoma: a case series. Vaccines 9(8):838","journal-title":"Vaccines"},{"issue":"29","key":"970_CR76","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.3748\/wjg.v16.i29.3603","volume":"16","author":"W Blonski","year":"2010","unstructured":"Blonski W, Kotlyar DS, Forde KA (2010) Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 16(29):3603","journal-title":"World J Gastroenterol"},{"issue":"1","key":"970_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpg.2004.10.004","volume":"19","author":"KA McGlynn","year":"2005","unstructured":"McGlynn KA, London WT (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19(1):3\u201323","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"10","key":"970_CR78","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A et al (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16(10):589\u2013604","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"970_CR79","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118(12):3030\u20133044","journal-title":"Int J Cancer"},{"key":"970_CR80","doi-asserted-by":"publisher","unstructured":"Kale A (2021) Hepatocellular carcinoma: diagnosis and surveillance. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.99839","DOI":"10.5772\/intechopen.99839"},{"key":"970_CR81","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/815105","author":"Y Maor","year":"2013","unstructured":"Maor Y, Malnick S (2013) Liver injury induced by anticancer chemotherapy and radiation therapy. Int J Hepatol. https:\/\/doi.org\/10.1155\/2013\/815105","journal-title":"Int J Hepatol"},{"issue":"33","key":"970_CR82","doi-asserted-by":"publisher","first-page":"11630","DOI":"10.3748\/wjg.v20.i33.11630","volume":"20","author":"M Tarocchi","year":"2014","unstructured":"Tarocchi M, Polvani S, Marroncini G, Galli A (2014) Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol 20(33):11630","journal-title":"World J Gastroenterol"},{"issue":"2","key":"970_CR83","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12072-016-9779-5","volume":"11","author":"M Wang","year":"2017","unstructured":"Wang M, Xi D, Ning Q (2017) Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatol Int 11(2):171\u2013180","journal-title":"Hepatol Int"},{"issue":"3","key":"970_CR84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/vaccines5030024","volume":"5","author":"AM Ortega-Prieto","year":"2017","unstructured":"Ortega-Prieto AM, Dorner M (2017) Immune evasion strategies during chronic hepatitis B and C virus infection. Vaccines 5(3):24","journal-title":"Vaccines"},{"issue":"1","key":"970_CR85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su JU et al (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295(1):65\u201373","journal-title":"JAMA"},{"issue":"12","key":"970_CR86","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024935","volume":"4","author":"GS Burns","year":"2014","unstructured":"Burns GS, Thompson AJ (2014) Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med 4(12):a024935","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"970_CR87","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3727\/096504018X15278771272963","volume":"27","author":"Q Xu","year":"2019","unstructured":"Xu Q, Gu S, Liang J, Lin Z et al (2019) The biological function of hepatitis B virus X protein in hepatocellular carcinoma. Oncol Res 27(4):509","journal-title":"Oncol Res"},{"issue":"30","key":"970_CR88","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.3748\/wjg.v20.i30.10238","volume":"20","author":"A Ali","year":"2014","unstructured":"Ali A, Abdel-Hafiz H, Suhail M, Al-Mars A et al (2014) Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J Gastroenterol 20(30):10238","journal-title":"World J Gastroenterol"},{"issue":"6","key":"970_CR89","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/ijms17060940","volume":"17","author":"S Liu","year":"2016","unstructured":"Liu S, Koh SS, Lee CG (2016) Hepatitis B virus X protein and hepatocarcinogenesis. Int J Mol Sci 17(6):940","journal-title":"Int J Mol Sci"},{"issue":"19","key":"970_CR90","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3748\/wjg.v25.i19.2279","volume":"25","author":"OO Ogunwobi","year":"2019","unstructured":"Ogunwobi OO, Harricharran T, Huaman et al (2019) Mechanisms of hepatocellular carcinoma progression. World J Gastroenterol 25(19):2279","journal-title":"World J Gastroenterol"},{"key":"970_CR91","unstructured":"Mahoney, FJ, Kane M (1999) Hepatitis B vaccine in: vaccines. Plotkin, SA, Orenstein, WA"},{"issue":"1","key":"970_CR92","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.jhep.2016.02.016","volume":"64","author":"D Durantel","year":"2016","unstructured":"Durantel D, Zoulim F (2016) New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus. J Hepatol 64(1):S117\u2013S131","journal-title":"J Hepatol"},{"key":"970_CR93","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/liv.13304","volume":"37","author":"EJ Gane","year":"2017","unstructured":"Gane EJ (2017) Future anti-HBV strategies. Liver Int 37:40\u201344","journal-title":"Liver Int"},{"issue":"8","key":"970_CR94","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3748\/wjg.v11.i8.1109","volume":"11","author":"K Fujiwara","year":"2005","unstructured":"Fujiwara K, Yokosuka O, Kojima H et al (2005) Importance of adequate immunosuppressive therapy for the recovery of patients with \u201clife-threatening\u201d severe exacerbation of chronic hepatitis B. World J Gastroenterol 11(8):1109\u20131114","journal-title":"World J Gastroenterol"},{"issue":"4","key":"970_CR95","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11901-010-0055-1","volume":"9","author":"V Rijckborst","year":"2010","unstructured":"Rijckborst V, Janssen HL (2010) The role of interferon in hepatitis B therapy. Curr Hepat Rep 9(4):231\u2013238","journal-title":"Curr Hepat Rep"},{"issue":"6","key":"970_CR96","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/v2061279","volume":"2","author":"ED Clercq","year":"2010","unstructured":"Clercq ED, F\u00e9rir G, Kaptein S, Neyts J (2010) Antiviral treatment of chronic hepatitis B virus (HBV) infections. Viruses 2(6):1279\u20131305","journal-title":"Viruses"},{"issue":"5","key":"970_CR97","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/hep.1840010502","volume":"1","author":"W Szmuness","year":"1981","unstructured":"Szmuness W, Stevens CE, Zang EA et al (1981) A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1(5):377\u2013385","journal-title":"Hepatology"},{"key":"970_CR98","unstructured":"McAleer WJ, Buynak EB, Maigetter RZ et al (1992) Human hepatitis B vaccine from recombinant yeast. 1984. Biotechnology (Reading, Mass.) 24:500\u2013502"},{"issue":"6","key":"970_CR99","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3748\/wjg.v19.i6.838","volume":"19","author":"G Vitaliti","year":"2013","unstructured":"Vitaliti G, Pratic\u00f2 AD, Cimino C et al (2013) Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow. World J Gastroenterol 19(6):838","journal-title":"World J Gastroenterol"},{"issue":"1","key":"970_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","volume":"15","author":"F Averhoff","year":"1998","unstructured":"Averhoff F, Mahoney F, Coleman P et al (1998) Immunogenicity of hepatitis B vaccines: implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 15(1):1\u20138","journal-title":"Am J Prev Med"},{"issue":"2","key":"970_CR101","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1517\/14740338.2.2.113","volume":"2","author":"MR Geier","year":"2003","unstructured":"Geier MR, Geier DA, Zahalsky AC (2003) A review of hepatitis B vaccination. Expert Opin Drug Saf 2(2):113\u2013122","journal-title":"Expert Opin Drug Saf"},{"issue":"9494","key":"970_CR102","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(05)67568-X","volume":"366","author":"AR Zanetti","year":"2005","unstructured":"Zanetti AR, Mariano A, Roman\u00f2 L et al (2005) Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366(9494):1379\u20131384","journal-title":"Lancet"},{"issue":"1","key":"970_CR103","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/cid\/cir270","volume":"53","author":"E Leuridan","year":"2011","unstructured":"Leuridan E, Van Damme P (2011) Hepatitis B and the need for a booster dose. Clin Infect Dis 53(1):68\u201375","journal-title":"Clin Infect Dis"},{"issue":"3","key":"970_CR104","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0149-2918(01)80044-8","volume":"23","author":"T Coates","year":"2001","unstructured":"Coates T, Wilson R, Patrick G et al (2001) Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 23(3):392\u2013403","journal-title":"Clin Ther"},{"issue":"24","key":"970_CR105","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.4254\/wjh.v7.i24.2503","volume":"7","author":"S Walayat","year":"2015","unstructured":"Walayat S, Ahmed Z, Martin D, Puli S et al (2015) Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol 7(24):2503","journal-title":"World J Hepatol"},{"issue":"6","key":"970_CR106","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4161\/hv.7.6.14986","volume":"7","author":"AH Roukens","year":"2011","unstructured":"Roukens AH, Visser LG (2011) Hepatitis B vaccination strategy in vaccine low and non-responders: a matter of quantity of quality? Hum Vaccin 7(6):654\u2013657","journal-title":"Hum Vaccin"},{"issue":"6","key":"970_CR107","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jhep.2020.01.012","volume":"72","author":"TC Tseng","year":"2020","unstructured":"Tseng TC, Liu CJ, Chang CT et al (2020) HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. J Hepatol 72(6):1105\u20131111","journal-title":"J Hepatol"},{"issue":"4","key":"970_CR108","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","volume":"142","author":"HL Chen","year":"2012","unstructured":"Chen HL, Lin LH, Hu FC et al (2012) Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 142(4):773\u2013781","journal-title":"Gastroenterology"},{"key":"970_CR109","unstructured":"World Health Organization (2020) Prevention of mother-to-child transmission of hepatitis B virus (HBV): Guidelines on antiviral prophylaxis in pregnancy. World Health Organization"},{"issue":"6","key":"970_CR110","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2174\/1389201022666210719162802","volume":"23","author":"M Zangiabadian","year":"2022","unstructured":"Zangiabadian M, Zamani A, Nasiri MJ et al (2022) Diagnostic accuracy and validity of serological and molecular tests for hepatitis B and C. Curr Pharm Biotechnol 23(6):803\u2013817","journal-title":"Curr Pharm Biotechnol"},{"issue":"40","key":"970_CR111","doi-asserted-by":"publisher","first-page":"14615","DOI":"10.3748\/wjg.v20.i40.14615","volume":"20","author":"S Datta","year":"2014","unstructured":"Datta S, Chatterjee S, Veer V (2014) Recent advances in molecular diagnostics of hepatitis B virus. World J Gastroenterol 20(40):14615","journal-title":"World J Gastroenterol"},{"issue":"1","key":"970_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/IBRR\/2017\/31171","volume":"7","author":"V Sharma","year":"2017","unstructured":"Sharma V, Kumar D, Dhull D et al (2017) Molecular detection of hepatitis B viruses (HBV). Int Blood Res Rev 7(1):1\u20136","journal-title":"Int Blood Res Rev"},{"issue":"1","key":"970_CR113","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/1596-3519.62625","volume":"9","author":"JC Forbi","year":"2010","unstructured":"Forbi JC, Obagu JO, Gyar SD et al (2010) Application of dried blood spot in the sero-diagnosis of hepatitis B infection (HBV) in an HBV hyper-endemic nation. Ann Afr Med 9(1):44","journal-title":"Ann Afr Med"},{"key":"970_CR114","unstructured":"Tesfaye T (2020) A mathematical model analysis on the spread and control of chronic and hyper toxic forms of hepatitis b virus in Ethiopia (Doctoral dissertation)"},{"issue":"4","key":"970_CR115","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5501\/wjv.v4.i4.323","volume":"4","author":"LM Villar","year":"2015","unstructured":"Villar LM, Cruz HM, Barbosa JR et al (2015) Update on hepatitis B and C virus diagnosis. World J Virol 4(4):323","journal-title":"World J Virol"},{"issue":"8","key":"970_CR116","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1473-3099(02)00345-6","volume":"2","author":"M Torbenson","year":"2002","unstructured":"Torbenson M, Thomas DL (2002) Occult hepatitis B. Lancet Infect Dis 2(8):479\u2013486","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"970_CR117","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1086\/502012","volume":"23","author":"EG Playford","year":"2002","unstructured":"Playford EG, Hogan PG, Bansal AS et al (2002) Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine. Infect Control Hosp Epidemiol 23(2):87\u201390","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"40","key":"970_CR118","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.3748\/wjg.v18.i40.5729","volume":"18","author":"S Leonardi","year":"2012","unstructured":"Leonardi S, Pratic\u00f2 AD, Lionetti E et al (2012) Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. WJG 18(40):5729","journal-title":"WJG"},{"issue":"2","key":"970_CR119","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2307\/30140948","volume":"16","author":"RE Levitz","year":"1995","unstructured":"Levitz RE, Cooper BW, Regan HC (1995) Immunization with high-dose intradermal recombinant hepatitis B vaccinein healthcare workers who failed to respond to intramuscular vaccination. Infect Control Hosp Epidemiol 16(2):88\u201391","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 2","key":"970_CR120","first-page":"S33","volume":"89","author":"T Chanchairujira","year":"2006","unstructured":"Chanchairujira T, Chantaphakul N, Thanwandee T, Ong-Ajyooth L (2006) Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients. J Med Assoc Thai 89(Suppl 2):S33\u2013S40","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"970_CR121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4161\/hv.4.4.5687","volume":"4","author":"S Ghebrehewet","year":"2008","unstructured":"Ghebrehewet S, Baxter D, Falconer M, Paver K (2008) Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs). Hum Vaccin 4(4):280\u2013285","journal-title":"Hum Vaccin"},{"issue":"1","key":"970_CR122","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.ajkd.2009.03.010","volume":"54","author":"KA Barraclough","year":"2009","unstructured":"Barraclough KA, Wiggins KJ, Hawley CM et al (2009) Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. AJKD 54(1):95\u2013103","journal-title":"AJKD"},{"issue":"10","key":"970_CR123","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-2893.2010.01354.x","volume":"18","author":"F Fabrizi","year":"2011","unstructured":"Fabrizi F, Dixit V, Messa P, Martin P (2011) Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials. J Viral Hepat 18(10):730\u2013737","journal-title":"J Viral Hepat"},{"issue":"12","key":"970_CR124","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S1473-3099(12)70243-8","volume":"12","author":"JA Whitaker","year":"2012","unstructured":"Whitaker JA, Rouphael NG, Edupuganti S et al (2012) Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect Dis 12(12):966\u2013976","journal-title":"Lancet Infect Dis"},{"issue":"30","key":"970_CR125","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.3748\/wjg.v20.i30.10383","volume":"20","author":"M Filippelli","year":"2014","unstructured":"Filippelli M, Lionetti E, Gennaro A et al (2014) Hepatitis B vaccine by intradermal route in non responder patients: an update. WJG 20(30):10383","journal-title":"WJG"},{"issue":"12","key":"970_CR126","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","volume":"61","author":"A Bertoletti","year":"2012","unstructured":"Bertoletti A, Ferrari C (2012) Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61(12):1754\u20131764","journal-title":"Gut"},{"issue":"2","key":"970_CR127","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1128\/JVI.02008-08","volume":"83","author":"H Guo","year":"2009","unstructured":"Guo H, Jiang D, Ma D et al (2009) Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. Virol J 83(2):847\u2013858","journal-title":"Virol J"},{"key":"970_CR128","doi-asserted-by":"publisher","unstructured":"Zhang RN, Pan Q, Zhang Z et al (2015) Saturated fatty acid inhibits viral replication in chronic hepatitis B virus infection with nonalcoholic Fatty liver disease by toll-like receptor 4-mediated innate immune response. Hepat Mon 15(5):e27909. https:\/\/doi.org\/10.5812\/hepatmon.32636","DOI":"10.5812\/hepatmon.32636"},{"issue":"14","key":"970_CR129","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1021\/acs.jmedchem.8b00643","volume":"61","author":"W Embrechts","year":"2018","unstructured":"Embrechts W, Herschke F, Pauwels F, Stoops et al (2018) 2, 4-Diaminoquinazolines as dual toll-like receptor (TLR) 7\/8 modulators for the treatment of hepatitis B virus. J Med Chem 61(14):6236\u20136246","journal-title":"J Med Chem"},{"issue":"9","key":"970_CR130","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/acsinfecdis.5b00039","volume":"1","author":"CC Colpitts","year":"2015","unstructured":"Colpitts CC, Verrier ER, Baumert TF (2015) Targeting viral entry for treatment of hepatitis B and C virus infections. ACS Infect Dis 1(9):420\u2013427","journal-title":"ACS Infect Dis"},{"issue":"4","key":"970_CR131","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12072-016-9718-5","volume":"10","author":"ER Verrier","year":"2016","unstructured":"Verrier ER, Colpitts CC, Sureau C et al (2016) Hepatitis B virus receptors and molecular drug targets. Hepatol Int 10(4):567\u2013573","journal-title":"Hepatol Int"},{"issue":"1","key":"970_CR132","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.gastro.2014.04.030","volume":"147","author":"S Urban","year":"2014","unstructured":"Urban S, Bartenschlager R, Kubitz R et al (2014) Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology 147(1):48\u201364","journal-title":"Gastroenterology"},{"issue":"11","key":"970_CR133","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.3390\/ijms23116052","volume":"23","author":"P Bhardwaj","year":"2022","unstructured":"Bhardwaj P, Kant R, Behera SP et al (2022) Next-generation diagnostic with CRISPR\/Cas: beyond nucleic acid detection. Int J Mol Sci 23(11):6052","journal-title":"Int J Mol Sci"},{"issue":"3","key":"970_CR134","doi-asserted-by":"publisher","first-page":"e00168","DOI":"10.1128\/CMR.00168-19","volume":"33","author":"N Kumar","year":"2020","unstructured":"Kumar N, Sharma S, Kumar R et al (2020) Host-directed antiviral therapy. Clin Microbiol Rev 33(3):e00168-e219","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"970_CR135","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/jac\/dkg163","volume":"51","author":"P Karayiannis","year":"2003","unstructured":"Karayiannis P (2003) Hepatitis B virus: old, new and future approaches to antiviral treatment. J Antimicrob Chemother 51(4):761\u2013785","journal-title":"J Antimicrob Chemother"},{"key":"970_CR136","doi-asserted-by":"publisher","unstructured":"Samani ZN, Kopaei MR (2018) Effective medicinal plants in treating hepatitis B. Int J Pharm Sci 9(9):3589\u20133596. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.9(9).3589-96","DOI":"10.13040\/IJPSR.0975-8232.9(9).3589-96"},{"issue":"1","key":"970_CR137","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/13102818.2016.1240593","volume":"31","author":"MH Siddiqui","year":"2017","unstructured":"Siddiqui MH, Alamri SA, Al-Whaibi MH et al (2017) A mini-review of anti-hepatitis B virus activity of medicinal plants. Biotechnol Biotechnol Equip 31(1):9\u201315","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"5","key":"970_CR138","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5582\/bst.2016.01110","volume":"10","author":"J Xia","year":"2016","unstructured":"Xia J, Inagaki Y, Song P et al (2016) Advance in studies on traditional Chinese medicines to treat infection with the hepatitis B virus and hepatitis C virus. Biosci Trends 10(5):327\u2013336","journal-title":"Biosci Trends"},{"issue":"34","key":"970_CR139","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.3748\/wjg.v23.i34.6252","volume":"23","author":"ZQ Wei","year":"2017","unstructured":"Wei ZQ, Zhang YH, Ke CZ et al (2017) Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation. World J Gastroenterol 23(34):6252","journal-title":"World J Gastroenterol"},{"key":"970_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2014.10.050","volume":"160","author":"PH Wei","year":"2015","unstructured":"Wei PH, Wu SZ, Mu XM et al (2015) Effect of alcohol extract of Acanthus ilicifolius L. on anti-duck hepatitis B virus and protection of liver. J Ethnopharmacol 160:1\u20135","journal-title":"J Ethnopharmacol"},{"key":"970_CR141","first-page":"71","volume":"93","author":"R Mehrotra","year":"1991","unstructured":"Mehrotra R, Rawat S, Kulshreshtha DK et al (1991) In vitro effect of Phyllanthus amarus on hepatitis B virus. IJMR 93:71\u201373","journal-title":"IJMR"},{"issue":"2","key":"970_CR142","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/JOE-21-0194","volume":"251","author":"R Krist\u00f3fi","year":"2021","unstructured":"Krist\u00f3fi R, Eriksson JW (2021) Metformin as an anti-inflammatory agent: a short review. Int J Endocrinol 251(2):R11\u2013R22","journal-title":"Int J Endocrinol"},{"issue":"3","key":"970_CR143","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/molecules21030336","volume":"21","author":"B Li","year":"2016","unstructured":"Li B, Guo QL et al (2016) New anti-HBV C-boivinopyranosyl flavones from Alternanthera philoxeroides. Molecules 21(3):336","journal-title":"Molecules"},{"issue":"2","key":"970_CR144","first-page":"39","volume":"4","author":"X Cui","year":"2010","unstructured":"Cui X, Wang Y, Kokudo N et al (2010) Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Biosci Trends 4(2):39\u201347","journal-title":"Biosci Trends"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-00970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-023-00970-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-00970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T02:21:51Z","timestamp":1685672511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-023-00970-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":144,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1007\/s42770-023-00970-y","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data relevant to the study is included in the article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}